Clinical repigmentation patterns in paediatric vitiligo

Repigmentation is an essential outcome measure in vitiligo. However, clinical studies describing vitiligo repigmentation patterns are lacking.

[1]  D. Roop,et al.  Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors. , 2015, The Journal of investigative dermatology.

[2]  M. Picardo,et al.  Developing core outcome set for vitiligo clinical trials: international e‐Delphi consensus , 2015, Pigment cell & melanoma research.

[3]  I. Jackson,et al.  Maintenance of distinct melanocyte populations in the interfollicular epidermis , 2015, Pigment cell & melanoma research.

[4]  K. Thomas,et al.  Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials , 2012, The British journal of dermatology.

[5]  M. Herlyn,et al.  Dermis‐derived stem cells: a source of epidermal melanocytes and melanoma? , 2011, Pigment cell & melanoma research.

[6]  Yun-Seok Yang,et al.  Clinical study of repigmentation patterns with either narrow‐band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients , 2010, International journal of dermatology.

[7]  U. Suter,et al.  Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin , 2009, Cell.

[8]  R. Falabella.  VITILIGO AND THE MELANOCYTE RESERVOIR , 2009, Indian journal of dermatology.

[9]  C. Garbe,et al.  Inflammatory nodules around the axilla: an uncommon localization of orf virus infection , 2009, Clinical and experimental dermatology.

[10]  L. Davids,et al.  A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem‐cell reservoir of melanocytes? , 2009, Clinical and experimental dermatology.

[11]  Gordon Hiroshi Sasaki,et al.  Fractional CO2 laser resurfacing of photoaged facial and non-facial skin: Histologic and clinical results and side effects , 2009, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[12]  T. Jouary,et al.  Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non‐segmental vitiligo , 2008, Pigment cell & melanoma research.

[13]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[14]  D. Ashcroft,et al.  Interventions for vitiligo. , 2006, The Cochrane database of systematic reviews.

[15]  Sung Bin Cho,et al.  Various Patterns of Repigmentation after Narrowband UVB Monotherapy in Patients with Vitiligo , 2005, The Journal of dermatology.

[16]  S. Dogra,et al.  Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. , 2004, Journal of the American Academy of Dermatology.

[17]  D. Tobin,et al.  Melanocytes are not absent in lesional skin of long duration vitiligo. , 2000, The Journal of pathology.

[18]  C. Yu,et al.  Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. , 2000, Journal of dermatological science.

[19]  J. A. Burch,et al.  KIT expression reveals a population of precursor melanocytes in human skin. , 1996, The Journal of investigative dermatology.

[20]  J Cui,et al.  Role of hair follicles in the repigmentation of vitiligo. , 1991, The Journal of investigative dermatology.

[21]  J. Ortonne,et al.  PUVA‐induced repigmentation of vitiligo: a histochemical (split‐DOPA) and ultrastructural study , 1979, The British journal of dermatology.